Not logged in...
About USC Norris
Research
Patient Care
CISO
Search Trials
FAQ - Trials
Contact Us - Trials
Membership
Education
Shared Resources
Support USC Norris
Outreach
Login/Logout
Contact USC Norris
Support Us
Donate
Menu
USC Norris
»
Clinical Trials
Trial NC-HEM-14-6
Open Label, Adaptive Design, Ascending, Multiple-Dose Study to Evaluate Safety and Efficacy of BMS-986004 (Anti-CD40L dAb) in Adult Subjects with Primary Immune Thrombocytopenia (ITP)
Type:
Treatment
Phase:
Status:
Not Open (Closed)
Treatments:
Randomized:
No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
Howard Liebman, M.D.
Other Trial Staff:
Christine Duran, Coordinator, Christine Duran, D.M., Melissa Peralta, D.M., Teresa Olea, R.N., Donna Fernando, Coordinator, Meena Ibrahim, D.M.
Staff may
log in
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.